248
Participants
Start Date
September 27, 2024
Primary Completion Date
October 1, 2025
Study Completion Date
January 1, 2026
pimavanserin tartrate
pimavanserin tartrate, 34 mg, capsule, once daily by mouth for 6 weeks
placebo
placebo, capsule, once daily by mouth for 6 weeks
RECRUITING
Beijing Hospital, Beijing
RECRUITING
Xuan Wu Hospital, Beijing
RECRUITING
Peking University Sixth Hospital, Beijing
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
Ruijin Hospital, Shanghai
RECRUITING
Nanjing Drum Tower Hospital, Nanjing
RECRUITING
Zhongda Hospital Southeast University, Nanjing
RECRUITING
The Second Affiliated Hospital of Soochow University, Suzhou
RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
RECRUITING
Huai'an Second People's Hospital, Huaian
RECRUITING
The First Affiliated Hospital of Anhui Medical University, Hefei
RECRUITING
Qilu Hospital of Shandong University, Jinan
RECRUITING
Qilu Hospital of Shandong University(Qingdao), Qingdao
RECRUITING
Tianjin Huanhu Hospital, Tianjin
RECRUITING
The Second Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
The First Affiliated Hospital of Fujian Medical University, Fuzhou
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
The Third Xiangya Hospital of Central South University, Changsha
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
Guangdong Provincial Peoples Hospital, Guangzhou
RECRUITING
The Affiliated Hospital of Guizhou Medical University, Guiyang
RECRUITING
West China Hospital of Sichuan University, Chengdu
RECRUITING
Mianyang Central Hospital, Mianyang
RECRUITING
People's Hospital of Ningxia Hui Autonomous Region, Yinchuan
RECRUITING
The Second Hospital of HeBei Medical University, Shijiazhuang
RECRUITING
Inner Mongolia Autonomous Region People's Hospital, Hohhot
Tasly Pharmaceutical Group Co., Ltd
INDUSTRY